October 20-21 2025

The Joseph B. Martin Conference Center at Harvard Medical School

2025 Biomarkers of Aging Conference

The Premier Conference on Biomarkers of Aging.

Anti-aging therapies are nearing the clinic - but without standardized, validated tools to measure aging, progress stalls. Our annual Conference brings together global leaders in geroscience to define and advance reliable biomarkers of aging, essential for evaluating the safety and impact of longevity interventions.

2025 Agenda

Short Talks, Poster Sessions and Flash Talks.

Themes include: “Molecules to organs: biomarkers of aging”, “Understanding biomarker influences: determinants of biomarkers”, “Innovative tools for biomarkers”, “New biomarker studies and collections”.
Catered light breakfast, lunch, and refreshments.
Full Day 1 Program coming soon.
Talks, Poster Sessions, and Flash Talks.
Themes include: Longevity Biotech and Aging Biomarkers, Biomarker Standardization, Qualifications, and Regulation, Biomarkers guided Gerotherapeutics, Clinical Biomarkers and Outcomes, Role of Open Innovation, including XPRIZE Healthspan and Biomarkers of Aging Challenge, with presentations by winning teams “Making biomarkers clinically useful”.
Catered light breakfast, lunch, and refreshments.
Full Day 2 Program coming soon.

2025 Speakers
(more to be announced soon!)

Joe Betts-LaCroix

CEO
Retro Biosciences
Eileen Crimmins

AARP Chair in Gerontology
USC Davis School of Gerontology
Luigi Ferrucci

Director
National Institute on Aging
Steve Horvath

Principle Investigator
Altos Labs
Andrea Maier

Professor of Medicine
National University of Singapore
Terrie Moffitt

Nannerl O. Keohane University Professor of Psychology
Duke University
Paola Sebastiani

Director of the Biostatistics, Epidemiology and Research Design Center @ Tufts CTSI
Shigeo Horie

Professor and Chair, Department of Innovative Longevity, Juntendo University Graduate School of Medicine
Wolfgang Wagner

Director of the Institute of Stem Cell Biology, RWTH Aachen University Hospital
Bo Wang

Chief Artificial Intelligence Scientist
University Health Network
Alex Zhavoronkov

Founder and CEO, InSilico Medicine

2025 Conference Organizers

Chiara Herzog, PhD
Executive Committee

Andrea Cipriano, PhD
Executive Committee

Nicholas Fiorenza
Core Team

Ludger Goeminne, PhD
Core Team

Luisa Georgiana Baca, PhD
Core Team

Allison Deuttmann
Executive Committee

Jesse Poganik, PhD
Executive Co-Director

Vadim Gladyshev, PhD
Conference Chair

Dane Gobel
Executive Co-Director

Mahdi Moqri, PhD, MBA
Executive Co-Director

2025 Sponsors & Media Partners

More to be announced soon. Get in touch to learn about sponsorship opportunities!

2024 Highlights

Nearly 500 attendees from over 30 countries and 28 US States attended, with two days of cutting-edge programming featuring 48 talks by leading scientists, industry experts, and top poster presenters, sharing insights to support the entire field. Over 50 flash talks and 100 posters showcased research from prestigious universities and life sciences companies.

Biomarkers of Aging Challenge Phase I and Phase II Winners Announced

The Challenge aims to generate the most accurate predictive models for aging biomarkers, including mortality and multi-morbidity. Phase I and II winners were awarded a total of $100,000 USD.

The Longevity Study Pilot Launched

The Longevity Study is a longitudinal multi-modal deep-profiling human health study, dedicated to understanding how aging affects us at molecular and functional level. This study contributes substantially to our understanding of how our bodies change as we age and which molecular changes drive functional decline. We reached several major milestones: 1) launching our Study and 2) achieving our target of 100 participants and collected 300+ samples.

Sponsorship Impact

With the support of 30 mission-aligned sponsors and partners, we supported meaningful collaborations and long-term ROI for all involved.

Community Momentum

New connections and collaborations formed, lasting friendships developed, and familiar faces reconnected, all sharing a passion for advancing the science of longevity.

Inquiries? Like to sponsor? Get in touch with the team: community@agingconsortium.org

Thank you 2024 Speakers!

Austin Argentieri, PhD
Harvard University

Omar Abudayyeh, PhD
Harvard University

Nir Barzilai, MD
Albert Einstein
College of Medicine

Ed Boyden, PhD
MIT

Andrew Brack, PhD
ARPA-H

Jason Buenrostro, PhD
Harvard University

Luigi Ferrucci, PhD
National Institute of Aging

Eric Morgen, MD
BioAge Labs

David Furman, PhD
Buck Institute

Vadim Gladyshev, PhD
Harvard University

Christin Glorioso,
MD, PhD
NeuroAge Therapeutics

Dane Gobel
Methuselah Foundation

Dave Gobel
Methuselah Foundation

Jonathan Gootenberg, PhD
Harvard University

Sara Hägg, PhD
Karolinska Institutet

Chiara Herzog, PhD
University of Innsbruck

Steve Horvath, PhD
Altos Labs

Jamie Justice, PhD
XPRIZE Healthspan

Gordan Lauc, PhD
University of Zagreb

Xiao-Jun Ma, PhD
Alamar Biosciences

Raymond H. Mak, MD
Harvard University

Andrea Maier, MD, PhD
NUS

Riccardo E. Marioni, PhD
University of Edinburgh

Mahdi Moqri, PhD, MBA
Harvard University

Seth Paulson
Methuselah Foundation

Viviana Perez, PhD
NIH

Jesse Poganik, PhD
Harvard University

Julian Reinhard
Evotec

Björn Schumacher, PhD
University of Cologne

Vittorio Sebastiano, PhD
Stanford University

Raghav Sehgal, PhD
Yale University

David Sinclair, PhD
Harvard University

Michael Snyder, PhD
Stanford University

Alexandra Stolzing, PhD
Loughborough University

Gavin Zhou, PhD
Regen Bio

Waylon Hastings, PhD
Texas A&M

John Earls, PhD
Buck Institute

George Church, PhD
Wyss Institute

Jessica Lasky-Su, PhD
Harvard University

Jessica Kasamoto, MSc
Yale University

Alexander Tyshkovskiy, PhD
Harvard University

John Tsang, PhD
Yale University

Tina Woods, MBA
Collider Health

Eric Verdin, MD
Buck Institute

Tony Wyss-Coray, PhD
Stanford University

Kejun Albert Ying, PhD
Harvard University

Lynne Cox, PhD
Wellcome Leap

Christian Behrens,
PhD, RD
Bayer

Revisit our 2024 Day 2 Talks

Day 2 focused on the translational and clinical dimensions of the field, fostering discussions and collaboration between scientists, clinicians, and entrepreneurs.